Here’s whether Merck & Co., Inc. (MRK) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.35% over 10 days); strong 1-year return of +77.2%; 3-month momentum positive (+24.6%); rising volume confirms the move (1.23x 30d avg). Concerns: RSI 87 — overbought, elevated pullback risk. Currently 1.3% off its 52-week high. Score: +6/7.
MRK is in a confirmed uptrend, trading above both its 50-day ($128.00) and 200-day ($115.30) moving averages. With an RSI of 86.7, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +77.2% compares to +20.5% for SPY (beat the market by 56.7%).
$10,000 invested 1 year ago→ $17,722 today
vs. S&P 500 (SPY) — same period beat market by 56.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($115.30)
✓Above 50-day MA ($128.00)
!RSI(14) neutral zone (30–70) — currently 86.7
✓Positive return (+77.2%)
✓Within 10% of period high (−1.3%)
Period Range $152.55
$77.58$154.49
RSI (14) 86.7
0 · OversoldOverbought · 100
Key Metrics
Price$152.55
Period Return+77.2%
Period High$154.49
Period Low$77.58
Drawdown−1.3%
MA-50$128.00
MA-200$115.30
RSI (14)86.7
Avg Volume (30d)10.0M
vs. SPYbeat by 56.7%
Return Rank#171 of 999
Trend Signals
Price is above the 200-day moving average ($115.30)
Price is above the 50-day moving average ($128.00)